These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 19923)

  • 1. Naloxone reversal of ketobemidone induced respiratory, circulatory and narcotic effects in dogs.
    Aasen AO; Holst-Larsen H; Ormstad K; Rugstad HE
    Acta Pharmacol Toxicol (Copenh); 1977; 41 Suppl 2():118-28. PubMed ID: 19923
    [No Abstract]   [Full Text] [Related]  

  • 2. Naloxone: a potent ketobemidone antagonist in man.
    Holst-Larsen H; Aasen AO; Rugstad HE
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):91-5. PubMed ID: 40393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
    Freye E; Neruda B; Smith OW
    Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid-mediated drug actions cannot be concluded from naloxone induced reversal of anti-nociceptive effects in behavioural tests only.
    Lötsch J; Tegeder I
    Eur J Pain; 2010 Nov; 14(10):981-4. PubMed ID: 21070957
    [No Abstract]   [Full Text] [Related]  

  • 5. Antagonism by naloxone of narcotic-induced respiratory depression and analgesia.
    McGilliard KL; Takemori AE
    J Pharmacol Exp Ther; 1978 Nov; 207(2):494-503. PubMed ID: 30841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No hyperalgesia following opioid withdrawal after the oripavine derivative etorphine compared to remifentanil and sufentanil.
    Freye E; Levy JV
    Eur J Anaesthesiol; 2010 Feb; 27(2):174-80. PubMed ID: 20077594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Minidose naloxone reverses respiratory depression, but not analgesia, at the end of narcotic-supplemented anesthesia].
    Pizov R; Shir Y; Perel A
    Harefuah; 1987 Jan; 112(2):68-70. PubMed ID: 2885248
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of remifentanil for inducing apnea during diagnostic imaging in sedated pediatric patients.
    Jöhr M; Berger TM; Burki S; Schmid E
    Paediatr Anaesth; 2008 Dec; 18(12):1221-2. PubMed ID: 18673312
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiopulmonary effects of carfentanil in dama gazelles (Gazella dama).
    Schumacher J; Heard DJ; Young L; Citino SB
    J Zoo Wildl Med; 1997 Jun; 28(2):166-70. PubMed ID: 9279405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of fentanyl reversal by naloxone at varying arterial carbon dioxide tensions in dogs.
    Mills CA; Flacke JW; Miller JD; Davis LJ; Bloor BC; Flacke WE
    Anesth Analg; 1988 Aug; 67(8):730-6. PubMed ID: 3134834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged apnea after remifentanil.
    Nelson RY; Bretz B; Egan TD
    J Clin Anesth; 2007 Feb; 19(1):60-3. PubMed ID: 17321930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced respiratory depression.
    Lötsch J; Skarke C; Schneider A; Hummel T; Geisslinger G
    Clin Pharmacol Ther; 2005 Sep; 78(3):278-87. PubMed ID: 16153398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of naloxone to reverse carfentanil citrate-induced hypoxemia and cardiopulmonary depression in Rocky Mountain wapiti (Cervus elaphus nelsoni).
    Moresco A; Larsen RS; Sleeman JM; Wild MA; Gaynor JS
    J Zoo Wildl Med; 2001 Mar; 32(1):81-9. PubMed ID: 12790400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone reversal of oxymorphone effects in dogs.
    Copland VS; Haskins SC; Patz J
    Am J Vet Res; 1989 Nov; 50(11):1854-8. PubMed ID: 2482683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of alfentanil and fentanyl in short operations with special reference to their duration of action and postoperative respiratory depression.
    van Leeuwen L; Deen L; Helmers JH
    Anaesthesist; 1981 Aug; 30(8):397-9. PubMed ID: 6116461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide.
    Lewanowitsch T; Miller JH; Irvine RJ
    Life Sci; 2006 Jan; 78(7):682-8. PubMed ID: 16102783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of cholinergic mechanisms in the medulla oblongata reverse intravenous opioid-induced respiratory depression.
    Willette RN; Doorley BM; Sapru HN
    J Pharmacol Exp Ther; 1987 Jan; 240(1):352-8. PubMed ID: 3806396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intramuscular administration of low doses of medetomidine and medetomidine-butorphanol in middle-aged and old dogs.
    Muir WW; Ford JL; Karpa GE; Harrison EE; Gadawski JE
    J Am Vet Med Assoc; 1999 Oct; 215(8):1116-20. PubMed ID: 10530324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central effects of morphine on GI motility in conscious dogs.
    Takahashi T; Tsuchida D; Pappas TN
    Brain Res; 2007 Aug; 1166():29-34. PubMed ID: 17669372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of the neuroleptanalgesic effect of droperidolfentanyl in the dog by 4-aminopyridine and naloxone.
    Booth NH; Hatch RC; Crawford LM
    Am J Vet Res; 1982 Jul; 43(7):1227-31. PubMed ID: 6125116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.